Multiple Introductions of Salmonella enterica Serovar Typhi H58 with Reduced Fluoroquinolone Susceptibility into Chile.

Maes, Mailis; Dyson, Zoe A; Higginson, Ellen E; Fernandez, Alda; Araya, Pamela; Tennant, Sharon M; Baker, Stephen; Lagos, Rosanna; Levine, Myron M; Hormazabal, Juan Carlos; Dougan, Gordon

Maes, Mailis; Dyson, Zoe A; Higginson, Ellen E; Fernandez, Alda; Araya, Pamela; Tennant, Sharon M; Baker, Stephen; Lagos, Rosanna; Levine, Myron M; Hormazabal, Juan Carlos; Dougan, Gordon.

Emerg Infect Dis ; 26(11): 2736-2740, 2020 11.

Article en En | MEDLINE | ID: mdl-33079054

RESUMEN

Salmonella enterica serovar Typhi H58, an antimicrobial-resistant lineage, is globally disseminated but has not been reported in Latin America. Genomic analysis revealed 3 independent introductions of Salmonella Typhi H58 with reduced fluoroquinolone susceptibility into Chile. Our findings highlight the utility of enhanced genomic surveillance for typhoid fever in this region.

Asunto(s)

Antibacterianos/farmacología; Farmacorresistencia Bacteriana; Fluoroquinolonas/farmacología; Salmonella typhi; Fiebre Tifoidea; Chile/epidemiología; Humanos; Pruebas de Sensibilidad Microbiana; Salmonella typhi/efectos de los fármacos; Salmonella typhi/genética; Fiebre Tifoidea/epidemiología; Fiebre Tifoidea/microbiología

Palabras clave

Chile; Salmonella Typhi H58; South America; antimicrobial resistance; bacteria; enteric diseases; fluoroquinolone resistance; genotyping; whole-genome sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Salmonella typhi / Fiebre Tifoidea / Fluoroquinolonas / Farmacorresistencia Bacteriana / Antibacterianos Límite: Humans País/Región como asunto: America do sul / Chile Idioma: En Revista: Emerg Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google